Cita APA

Kang, Y., Rha, S. Y., Tassone, P., Barriuso, J., Yu, R., Szado, T., . . . Bang, Y. (2014). A phase IIa dose-finding and safety study of first-line pertuzumab in combination with trastuzumab, capecitabine and cisplatin in patients with HER2-positive advanced gastric cancer. Nature Publishing Group.

Chicago Style Citation

Kang, Y-K, S Y. Rha, P. Tassone, J. Barriuso, R. Yu, T. Szado, A. Garg, i Y-J Bang. A Phase IIa Dose-finding and Safety Study of First-line Pertuzumab in Combination With Trastuzumab, Capecitabine and Cisplatin in Patients With HER2-positive Advanced Gastric Cancer. Nature Publishing Group, 2014.

Cita MLA

Kang, Y-K, et al. A Phase IIa Dose-finding and Safety Study of First-line Pertuzumab in Combination With Trastuzumab, Capecitabine and Cisplatin in Patients With HER2-positive Advanced Gastric Cancer. Nature Publishing Group, 2014.